View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Brigatinib 180, Non-Small Cell Lung Cancer, Second Line, Cycle 2+
Protocol-ID: 55 V1.0 (Mini), BRGT180, NSCLC, second line, C2+Indication(s)
- Lung Carcinoma, Non-Small Cell (ALK+); ICD-10 C34.-
Links
- Brigatinib (alunbrig) [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 21.12.2018